[DOI] [PubMed] [Google Scholar] 93.Arpino V., Brock M., Gill S.E
Research Animal Research In rats given 30 or 60 mg ALCAR, the 60 mg group showed the best neurotransmitter status, leading researchers to suggest ALCAR may have positive effects for depression and dementia
The FDA has explicitly warned that salt forms are not the approved active pharmaceutical ingredient and that products using them are not the same as FDA-approved semaglutide
FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014
Retatrutide Phase 3 TRIUMPH-4 (NCT05931367, 445 participants, 68 weeks) reported 28.7% body weight loss at 12 mg, 26.4% at 9 mg, vs 2.1% placebo
Compared to lean and overweight individuals, patients with both asthma and obesity tend to experience a higher frequency of healthcare visits, exacerbation rates, and greater reliance on medications [8, 9]